BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2044049)

  • 1. Ganglioside GM3:GD3 ratio as an index for the management of melanoma.
    Ravindranath MH; Tsuchida T; Morton DL; Irie RF
    Cancer; 1991 Jun; 67(12):3029-35. PubMed ID: 2044049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
    Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
    Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of melanoma-associated gangliosides in cancer patients.
    Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
    Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside profiles of experimental melanomas and of their melanosomal fractions.
    Vedralová E; Borovanský J; Hach P
    Melanoma Res; 1995 Apr; 5(2):87-92. PubMed ID: 7620344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
    Hamilton WB; Helling F; Lloyd KO; Livingston PO
    Int J Cancer; 1993 Feb; 53(4):566-73. PubMed ID: 8436430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma.
    Hersey P; Jamal O; Henderson C; Zardawi I; D'Alessandro G
    Int J Cancer; 1988 Mar; 41(3):336-43. PubMed ID: 3346097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
    Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
    Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside GD3 shedding by human malignant melanoma cells.
    Bernhard H; Meyer zum Büschenfelde KH; Dippold WG
    Int J Cancer; 1989 Jul; 44(1):155-60. PubMed ID: 2744885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
    Kanda S; Cochran AJ; Lee WR; Morton DL; Irie RF
    Int J Cancer; 1992 Nov; 52(5):682-7. PubMed ID: 1428227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
    Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
    Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangliosides of human melanoma.
    Tsuchida T; Saxton RE; Morton DL; Irie RF
    Cancer; 1989 Mar; 63(6):1166-74. PubMed ID: 2917320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.
    Hersey P
    Cancer Treat Res; 1991; 54():137-51. PubMed ID: 1673856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganglioside expression in human pancreatic islets.
    Dotta F; Colman PG; Lombardi D; Scharp DW; Andreani D; Pontieri GM; Di Mario U; Lenti L; Eisenbarth GS; Nayak RC
    Diabetes; 1989 Nov; 38(11):1478-83. PubMed ID: 2695376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosphingolipids in Bomirski transplantable melanomas in hamsters.
    Ren SL; Slominski A; Yu RK
    Cancer Res; 1989 Dec; 49(24 Pt 1):7051-6. PubMed ID: 2582447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside content of human platelets--differences in resting and activated platelets.
    Ferroni P; Lenti L; Martini F; Ciatti F; Pontieri GM; Gazzaniga PP
    Thromb Haemost; 1997 Mar; 77(3):548-54. PubMed ID: 9066009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies.
    Merritt WD; Casper JT; Lauer SJ; Reaman GH
    Cancer Res; 1987 Mar; 47(6):1724-30. PubMed ID: 3493067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New data on content and distribution of gangliosides in human milk.
    Rueda R; Puente R; Hueso P; Maldonado J; Gil A
    Biol Chem Hoppe Seyler; 1995 Dec; 376(12):723-7. PubMed ID: 9072047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronological changes in the ganglioside composition of human milk during lactation.
    Pan XL; Izumi T
    Early Hum Dev; 1999 May; 55(1):1-8. PubMed ID: 10367977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and spatial interrelationships between ganglioside glycosyltransferases and O-acetyltransferase(s) in human melanoma cells.
    Sjoberg ER; Varki A
    J Biol Chem; 1993 May; 268(14):10185-96. PubMed ID: 8486686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of gangliosides in human milk with a high performance thin layer chromatography (HPTLC)].
    Pan X; Hua T; Wu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Mar; 35(2):111-3. PubMed ID: 11413682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.